Pfizer Wins Patent Challenge by Mylan (AP via Yahoo! Finance)

Pfizer Wins Patent Challenge by Mylan (AP via Yahoo! Finance)
A federal court on Tuesday upheld the validity of a Pfizer Inc. U.S. patent covering the active ingredient in the multi-billion-dollar cardiovascular drug Norvasc, rebuffing a challenge from generic drug maker Mylan Laboratories Inc.